Therapeutic options for the 2019 novel coronavirus (2019-nCoV) von Li, Guangdi, De Clercq, Erik

Volltext

Approved Antiviral Drugs over the Past 50 Years von De Clercq, Erik, Li, Guangdi

Volltext

Mozobil® (Plerixafor, AMD3100), 10 years after its approval by the US Food and Drug Administration von De Clercq, Erik

Volltext

Highlights in Antiviral Drug Research: Antivirals at the Horizon von Clercq, Erik De

Volltext

Acyclic nucleoside phosphonates: a key class of antiviral drugs von Clercq, Erik De, Holý, Antonín

Volltext

Nucleoside analogs as a rich source of antiviral agents active against arthropod-borne flaviviruses von Eyer, Luděk, Nencka, Radim, de Clercq, Erik, Seley-Radtke, Katherine, Růžek, Daniel

Volltext

Structure‐based design, synthesis, and biological characterization of indolylarylsulfone derivatives as novel human immunodeficiency virus type 1 inhibitors with potent antiviral a... von Wang, Zhao, Wang, Wenbo, Gao, Zhen, Gao, Huizhan, Clercq, Erik De, Pannecouque, Christophe, Chen, Chin‐Ho, Kang, Dongwei, Zhan, Peng, Liu, Xinyong

Volltext

Synthesis, antibacterial, antifungal and antiviral activity evaluation of some new bis-Schiff bases of isatin and their derivatives von Jarrahpour, Aliasghar, Khalili, Dariush, De Clercq, Erik, Salmi, Chanaz, Brunel, Jean Michel

Volltext

Selective Anti-Herpesvirus Agents von De Clercq, Erik

Volltext

Genetic Diversity of SARS-CoV-2 over a One-Year Period of the COVID-19 Pandemic: A Global Perspective von Miao, Miao, Clercq, Erik De, Li, Guangdi

Volltext

Anti-HIV drugs: 25 compounds approved within 25 years after the discovery of HIV von De Clercq, Erik

Volltext

Design, Synthesis, and Mechanistic Study of 2-Pyridone-Bearing Phenylalanine Derivatives as Novel HIV Capsid Modulators von Zhang, Xujie, Sun, Lin, Xu, Shujing, Shao, Xiaoyu, Li, Ziyi, Ding, Dang, Jiang, Xiangyi, Zhao, Shujie, Cocklin, Simon, Clercq, Erik De, Pannecouque, Christophe, Dick, Alexej, Liu, Xinyong, Zhan, Peng

Volltext

Design, synthesis, and mechanism study of dimerized phenylalanine derivatives as novel HIV-1 capsid inhibitors von Zhang, Xujie, Sun, Lin, Meuser, Megan E., Zalloum, Waleed A., Xu, Shujing, Huang, Tianguang, Cherukupalli, Srinivasulu, Jiang, Xiangyi, Ding, Xiao, Tao, Yucen, Kang, Dongwei, De Clercq, Erik, Pannecouque, Christophe, Dick, Alexej, Cocklin, Simon, Liu, Xinyong, Zhan, Peng

Volltext

Current therapy for chronic hepatitis C: The role of direct-acting antivirals von Li, Guangdi, De Clercq, Erik

Volltext

The design of drugs for HIV and HCV von Clercq, Erik De

Volltext

Structure−Activity Relationship of New Anti-Hepatitis C Virus Agents: Heterobicycle−Coumarin Conjugates von Neyts, Johan, Clercq, Erik De, Singha, Raghunath, Chang, Yung Hsiung, Das, Asish R, Chakraborty, Subhasish K, Hong, Shih Ching, Tsay, Shwu-Chen, Hsu, Ming-Hua, Hwu, Jih Ru

Volltext

Identification of Boronate-Containing Diarylpyrimidine Derivatives as Novel HIV-1 Non-Nucleoside Reverse Transcriptase Inhibitors von Feng, Da, Lin, Hao, Jiang, Liyang, Wang, Zhao, Sun, Yanying, Zhou, Zhongxia, Clercq, Erik De, Pannecouque, Christophe, Kang, Dongwei, Zhan, Peng, Liu, Xinyong

Volltext

The AMD3100 story: The path to the discovery of a stem cell mobilizer (Mozobil) von De Clercq, Erik

Volltext

Current race in the development of DAAs (direct-acting antivirals) against HCV von De Clercq, Erik

Volltext

New anti-HIV agents and targets von Clercq, Erik De

Volltext